Schröder R, Sørensen M, Martínez F. "一种的合成方法" [P]. European Patent, EP 3078060 A1, 2015-04-12.
Mueller T C, Martínez F, Johansson L. "Method for the Synthesis of (2-(4-Chlorophenyl)-2H-tetrazol-5-yl)(3-hydroxyazetidin-1-yl)methanone" [P]. European Patent, EP 3762956 A1, 2024-03-13.
发明人马晓峰,何建平,杨光. "A Process for Preparing High-Purity (2-(4-Chlorophenyl)-2H-tetrazol-5-yl)(3-hydroxyazetidin-1-yl)methanone" [P]. 中国发明专利, 专利号 CN 112150525 B, 授权公告日 2023-09-10.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2019, 718, (12), 8868-8888.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2022, 1829, (4), 2745-2757.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of (2-(4-Chlorophenyl)-2H-tetrazol-5-yl)(3-hydroxyazetidin-1-yl)methanone Using HRMS and NMR". Biomed. Chromatogr., 2015, 454, (12), 7865-7881.